Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.8%

1 terminated/withdrawn out of 21 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
9(52.9%)
N/A
5(29.4%)
Phase 1
2(11.8%)
Phase 3
1(5.9%)
17Total
Phase 2(9)
N/A(5)
Phase 1(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT06607692Phase 1Recruiting

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Role: lead

NCT06840678Phase 1Recruiting

Home-based Transcranial Static Magnetic Field Stimulation (tSMS) of the Supplementary Motor Area in Parkinson's Disease

Role: lead

NCT06623162Phase 2Not Yet Recruiting

Sasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer Patients

Role: lead

NCT05914051Not ApplicableUnknown

PRELOAD-TAVI Trial

Role: lead

NCT04009876Phase 2Completed

A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

Role: lead

NCT05513755Not ApplicableUnknown

Cardioneuroablation in Reflex Syncope (CARDIOSYRE Trial)

Role: lead

NCT04525638Phase 2Unknown

A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours

Role: lead

NCT04010552Phase 2Unknown

Nalirinox Neo-pancreas RAS Mut ctDNA Study

Role: lead

NCT04420299Phase 2Terminated

Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

Role: lead

NCT04692116Not ApplicableCompleted

Parkinson's Disease (PD) Treated With Focused Ultrasound Subthalamotomy at an Early Stage

Role: lead

NCT03780426Phase 2Completed

tSMS in Essential Tremor

Role: lead

NCT04348695Phase 2Completed

Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.

Role: lead

NCT04410562Phase 3Completed

Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum

Role: collaborator

NCT03053843Not ApplicableUnknown

Mediterranean Diet Plus Extravirgin Olive Oil in the Prevention of Recurrent Arrhythmias. The PREDIMAR (PREvención Con DIeta Mediterránea de Arritmias Recurrentes) Trial

Role: lead

NCT04280380Unknown

Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy

Role: lead

NCT03989739Completed

A Cost Effectiveness Analysis of Robotic Versus Laparoscopic Distal Pancreatectomy

Role: lead

NCT02522065Completed

neuroQWERTY: a Transparent Patient-centered Outcome Method to Quantify Parkinsonian Motor Signs for Drug Trials

Role: lead

NCT02657681Phase 2Completed

Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

Role: lead

NCT02912871Not ApplicableCompleted

Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease

Role: lead

NCT02928432Phase 2Completed

SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone

Role: collaborator